Clinical Trial Update: Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis [Phase 2]

View source ↗

Summary

A Phase 2 trial compares once-daily FoamOtic Cipro to twice-daily Ciloxan ear drops for acute external otitis, reporting safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Externa

Drugs mentioned

• Ciloxan Ear Drops (ciprofloxacin)
• FoamOtic Cipro (ciprofloxacin)

Snippet

Sponsor: Otic Pharma | Conditions: Otitis Externa, Otorhinolaryngologic Diseases | Phase 2 | Status: COMPLETED